210 related articles for article (PubMed ID: 32112322)
1. Production and Application of Nanobodies for Membrane Protein Structural Biology.
Brunner JD; Schenck S
Methods Mol Biol; 2020; 2127():167-184. PubMed ID: 32112322
[TBL] [Abstract][Full Text] [Related]
2. A general protocol for the generation of Nanobodies for structural biology.
Pardon E; Laeremans T; Triest S; Rasmussen SG; Wohlkönig A; Ruf A; Muyldermans S; Hol WG; Kobilka BK; Steyaert J
Nat Protoc; 2014 Mar; 9(3):674-93. PubMed ID: 24577359
[TBL] [Abstract][Full Text] [Related]
3. Improving the yield of recalcitrant Nanobodies® by simple modifications to the standard protocol.
Kariuki CK; Magez S
Protein Expr Purif; 2021 Sep; 185():105906. PubMed ID: 33991675
[TBL] [Abstract][Full Text] [Related]
4. Development of a universal nanobody-binding Fab module for fiducial-assisted cryo-EM studies of membrane proteins.
Bloch JS; Mukherjee S; Kowal J; Filippova EV; Niederer M; Pardon E; Steyaert J; Kossiakoff AA; Locher KP
Proc Natl Acad Sci U S A; 2021 Nov; 118(47):. PubMed ID: 34782475
[TBL] [Abstract][Full Text] [Related]
5. Recombinant expression of nanobodies and nanobody-derived immunoreagents.
de Marco A
Protein Expr Purif; 2020 Aug; 172():105645. PubMed ID: 32289357
[TBL] [Abstract][Full Text] [Related]
6. High yield purification of nanobodies from the periplasm of E. coli as fusions with the maltose binding protein.
Salema V; Fernández LÁ
Protein Expr Purif; 2013 Sep; 91(1):42-8. PubMed ID: 23856605
[TBL] [Abstract][Full Text] [Related]
7. Mapping cytoskeletal protein function in cells by means of nanobodies.
Van Audenhove I; Van Impe K; Ruano-Gallego D; De Clercq S; De Muynck K; Vanloo B; Verstraete H; Fernández LÁ; Gettemans J
Cytoskeleton (Hoboken); 2013 Oct; 70(10):604-22. PubMed ID: 23818458
[TBL] [Abstract][Full Text] [Related]
8. Generation of Nanobodies against SlyD and development of tools to eliminate this bacterial contaminant from recombinant proteins.
Hu Y; Romão E; Vertommen D; Vincke C; Morales-Yánez F; Gutiérrez C; Liu C; Muyldermans S
Protein Expr Purif; 2017 Sep; 137():64-76. PubMed ID: 28668496
[TBL] [Abstract][Full Text] [Related]
9. Secretory production of a camelid single-domain antibody (VHH, nanobody) by the Serratia marcescens Lip system in Escherichia coli.
Asada T; Takagi D; Nakai M; Abe S; Yuasa K
Biochem Biophys Res Commun; 2021 Apr; 549():105-112. PubMed ID: 33667707
[TBL] [Abstract][Full Text] [Related]
10. Nanobodies as Probes for Protein Dynamics in Vitro and in Cells.
Dmitriev OY; Lutsenko S; Muyldermans S
J Biol Chem; 2016 Feb; 291(8):3767-75. PubMed ID: 26677230
[TBL] [Abstract][Full Text] [Related]
11. Engineering and characterization of GFP-targeting nanobody: Expression, purification, and post-translational modification analysis.
Weng D; Yang L; Xie Y
Protein Expr Purif; 2024 Sep; 221():106501. PubMed ID: 38782081
[TBL] [Abstract][Full Text] [Related]
12. Screening and Characterization Strategies for Nanobodies Targeting Membrane Proteins.
Veugelen S; Dewilde M; De Strooper B; Chávez-Gutiérrez L
Methods Enzymol; 2017; 584():59-97. PubMed ID: 28065273
[TBL] [Abstract][Full Text] [Related]
13. Nanobody-Mediated Neutralization Reveals an Achilles Heel for Norovirus.
Koromyslova AD; Devant JM; Kilic T; Sabin CD; Malak V; Hansman GS
J Virol; 2020 Jun; 94(13):. PubMed ID: 32321816
[TBL] [Abstract][Full Text] [Related]
14. Identification of conformation-selective nanobodies against the membrane protein insertase BamA by an integrated structural biology approach.
Kaur H; Hartmann JB; Jakob RP; Zahn M; Zimmermann I; Maier T; Seeger MA; Hiller S
J Biomol NMR; 2019 Jul; 73(6-7):375-384. PubMed ID: 31073665
[TBL] [Abstract][Full Text] [Related]
15. High-expression of monoclonal nanobodies used in the preparation of HRP-conjugated second antibody.
Ahmadvand D; Rahbarizadeh F; Vishteh VK
Hybridoma (Larchmt); 2008 Aug; 27(4):269-76. PubMed ID: 18707545
[TBL] [Abstract][Full Text] [Related]
16. Nanobody production can be simplified by direct secretion from Escherichia coli.
Iwaki T; Hara K; Umemura K
Protein Expr Purif; 2020 Jun; 170():105607. PubMed ID: 32062022
[TBL] [Abstract][Full Text] [Related]
17. A novel silk fibroin protein-based fusion system for enhancing the expression of nanobodies in Escherichia coli.
Yu J; Guo Y; Gu Y; Fan X; Li F; Song H; Nian R; Liu W
Appl Microbiol Biotechnol; 2022 Mar; 106(5-6):1967-1977. PubMed ID: 35243528
[TBL] [Abstract][Full Text] [Related]
18. Identification of Useful Nanobodies by Phage Display of Immune Single Domain Libraries Derived from Camelid Heavy Chain Antibodies.
Romao E; Morales-Yanez F; Hu Y; Crauwels M; De Pauw P; Hassanzadeh GG; Devoogdt N; Ackaert C; Vincke C; Muyldermans S
Curr Pharm Des; 2016; 22(43):6500-6518. PubMed ID: 27669966
[TBL] [Abstract][Full Text] [Related]
19. An efficient protocol towards site-specifically clickable nanobodies in high yield: cytoplasmic expression in Escherichia coli combined with intein-mediated protein ligation.
Ta DT; Redeker ES; Billen B; Reekmans G; Sikulu J; Noben JP; Guedens W; Adriaensens P
Protein Eng Des Sel; 2015 Oct; 28(10):351-63. PubMed ID: 26243885
[TBL] [Abstract][Full Text] [Related]
20. Challenges in the Structural-Functional Characterization of Multidomain, Partially Disordered Proteins CBP and p300: Preparing Native Proteins and Developing Nanobody Tools.
Bekesi A; Abdellaoui S; Holroyd N; Van Delm W; Pardon E; Pauwels J; Gevaert K; Steyaert J; Derveaux S; Borysik A; Tompa P
Methods Enzymol; 2018; 611():607-675. PubMed ID: 30471702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
